Pharmaceutical Technology6 天
XYF-19 by Xi’An Yufan Biotechnology for Hairy Cell Leukemia: Likelihood of Approval
XYF-19 is under clinical development by Xi'An Yufan Biotechnology and currently in Phase I for Hairy Cell Leukemia.
Pharmaceutical Technology6 天
XYF-19 by Xi’An Yufan Biotechnology for Mantle Cell Lymphoma: Likelihood of Approval
XYF-19 is under clinical development by Xi'An Yufan Biotechnology and currently in Phase I for Mantle Cell Lymphoma.